Assessing the prevalence of Female Genital Schistosomiasis and comparing the acceptability and performance of health worker-collected and self-collected cervical-vaginal swabs using PCR testing among women in North-Western Tanzania: The ShWAB study.
Journal
PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488
Informations de publication
Date de publication:
07 2023
07 2023
Historique:
received:
23
03
2023
accepted:
15
06
2023
revised:
18
07
2023
medline:
20
7
2023
pubmed:
6
7
2023
entrez:
6
7
2023
Statut:
epublish
Résumé
Female Genital Schistosomiasis (FGS) is a neglected disease of the genital tract due to the inflammatory response to the presence of Schistosoma haematobium eggs in the genital tract. The WHO has prioritized the improvement of diagnostics for FGS and previous studies have explored the PCR-based detection of Schistosoma DNA on genital specimens, with encouraging results. This study aimed to determine the prevalence of FGS among women living in an endemic district in North-western Tanzania, using PCR on samples collected though cervical-vaginal swabs, and to compare the performance of self-collected and healthcare worker-collected (operator-collected) samples, and the acceptability of the different sampling methods. A cross-sectional study was conducted involving 211 women living in 2 villages in the Maswa district of North-western Tanzania. Urine, self-collected and operator-collected cervical-vaginal swabs were obtained from participants. A questionnaire was administered, focusing on the comfortability in undergoing different diagnostic procedures. Prevalence of urinary schistosomiasis, as assessed by eggs in urine, was 8.5% (95%CI 5.1-13.1). DNA was pre-isolated from genital swabs and transported at room temperature to Italy for molecular analysis. Prevalence of active schistosomiasis, urinary schistosomiasis, and FGS were 10.0% (95% CI 6.3-14.8), 8.5% (95%CI 5.1-13.1), and 4.7% (95%CI 2.3-8.5), respectively. When real-time PCR was performed after a pre-amplification step, the prevalence of active schistosomiasis increased to 10.4% (95%CI 6.7-15.4), and FGS to 5.2% (95%CI 2.6-9.1). Of note, more cases were detected by self-collected than operator-collected swabs. The vast majority of participants (95.3%) declared that they were comfortable/very comfortable about genital self-sampling, which was indicated as the preferred sampling method by 40.3% of participants. The results of this study show that genital self-sampling followed by pre-amplified PCR on room temperature-stored DNA is a useful method from both technical and acceptability point of views. This encourages further studies to optimize samples processing, and identify the best operational flow to allow integration of FGS screening into women health programmes, such as HPV screening.
Sections du résumé
BACKGROUND
Female Genital Schistosomiasis (FGS) is a neglected disease of the genital tract due to the inflammatory response to the presence of Schistosoma haematobium eggs in the genital tract. The WHO has prioritized the improvement of diagnostics for FGS and previous studies have explored the PCR-based detection of Schistosoma DNA on genital specimens, with encouraging results. This study aimed to determine the prevalence of FGS among women living in an endemic district in North-western Tanzania, using PCR on samples collected though cervical-vaginal swabs, and to compare the performance of self-collected and healthcare worker-collected (operator-collected) samples, and the acceptability of the different sampling methods.
METHODS/PRINCIPAL FINDINGS
A cross-sectional study was conducted involving 211 women living in 2 villages in the Maswa district of North-western Tanzania. Urine, self-collected and operator-collected cervical-vaginal swabs were obtained from participants. A questionnaire was administered, focusing on the comfortability in undergoing different diagnostic procedures. Prevalence of urinary schistosomiasis, as assessed by eggs in urine, was 8.5% (95%CI 5.1-13.1). DNA was pre-isolated from genital swabs and transported at room temperature to Italy for molecular analysis. Prevalence of active schistosomiasis, urinary schistosomiasis, and FGS were 10.0% (95% CI 6.3-14.8), 8.5% (95%CI 5.1-13.1), and 4.7% (95%CI 2.3-8.5), respectively. When real-time PCR was performed after a pre-amplification step, the prevalence of active schistosomiasis increased to 10.4% (95%CI 6.7-15.4), and FGS to 5.2% (95%CI 2.6-9.1). Of note, more cases were detected by self-collected than operator-collected swabs. The vast majority of participants (95.3%) declared that they were comfortable/very comfortable about genital self-sampling, which was indicated as the preferred sampling method by 40.3% of participants.
CONCLUSIONS/SIGNIFICANCE
The results of this study show that genital self-sampling followed by pre-amplified PCR on room temperature-stored DNA is a useful method from both technical and acceptability point of views. This encourages further studies to optimize samples processing, and identify the best operational flow to allow integration of FGS screening into women health programmes, such as HPV screening.
Identifiants
pubmed: 37410782
doi: 10.1371/journal.pntd.0011465
pii: PNTD-D-23-00374
pmc: PMC10353784
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0011465Informations de copyright
Copyright: © 2023 Ursini et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Anal Chem. 2021 Mar 2;93(8):3710-3716
pubmed: 33596050
J Clin Microbiol. 2014 Sep;52(9):3303-9
pubmed: 24989601
Cytojournal. 2016 Apr 20;13:10
pubmed: 27168759
Parasitology. 2014 Dec;141(14):1841-55
pubmed: 24932595
Am J Trop Med Hyg. 2001 Sep;65(3):233-6
pubmed: 11561710
PLoS Negl Trop Dis. 2013 Aug 29;7(8):e2413
pubmed: 24009791
Acta Trop. 2020 Apr;204:105363
pubmed: 32035055
PLoS Negl Trop Dis. 2017 Nov 27;11(11):e0006101
pubmed: 29176778
BMJ. 2018 Dec 5;363:k4823
pubmed: 30518635
Int J Gynaecol Obstet. 2021 May;153(2):190-199
pubmed: 33316096
Trends Parasitol. 2012 Feb;28(2):58-65
pubmed: 22245065
N Engl J Med. 2019 Dec 26;381(26):2493-2495
pubmed: 31881137
Am J Trop Med Hyg. 2011 Mar;84(3):364-9
pubmed: 21363971
Clin Microbiol Infect. 2015 Jun;21(6):529-42
pubmed: 25843503
Wkly Epidemiol Rec. 2017 Dec 08;92(49):749-60
pubmed: 29218962
Int J Parasitol. 2016 Jun;46(7):395-404
pubmed: 27063073
Adv Parasitol. 2022;115:1-44
pubmed: 35249661
PLoS Negl Trop Dis. 2013;7(3):e2104
pubmed: 23556009
J Infect Dis. 2015 Jul 15;212(2):275-84
pubmed: 25725656
Lancet. 2014 Jun 28;383(9936):2253-64
pubmed: 24698483
Ann Trop Med Parasitol. 2008 Oct;102(7):625-33
pubmed: 18817603
PLoS Negl Trop Dis. 2022 Oct 12;16(10):e0010834
pubmed: 36223393
Am J Trop Med Hyg. 2014 Mar;90(3):546-52
pubmed: 24470560
BMJ. 2011 May 17;342:d2651
pubmed: 21586478
Parasit Vectors. 2018 Oct 23;11(1):552
pubmed: 30352631
Wellcome Open Res. 2020 Apr 2;5:61
pubmed: 33154978
Trends Parasitol. 2020 May;36(5):410-412
pubmed: 32298628
Reprod Health. 2022 Jan 24;19(1):20
pubmed: 35073965
Clin Microbiol Rev. 2015 Oct;28(4):939-67
pubmed: 26224883
PLoS Negl Trop Dis. 2020 Jul 14;14(7):e0008337
pubmed: 32663222
PLoS Negl Trop Dis. 2022 Nov 7;16(11):e0010901
pubmed: 36342912
Lancet Oncol. 2019 Feb;20(2):229-238
pubmed: 30658933
PLoS Negl Trop Dis. 2019 Apr 4;13(4):e0007025
pubmed: 30946746